To join a opioid use disorder clinical trial in United States, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United States directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.

What phases are opioid use disorder trials in United States?

Active opioid use disorder trials in United States span Phase 4, Phase 2, Phase 3, Phase 1, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.

Browse More

All United States Trials → Global opioid use disorder Trials → All Countries → All Trials →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology

Active Trials in United States (24)

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Cortical rTMS as a Treatment for Depression

Postpartum Intervention for Mothers With Opioid Use Disorders (R33)

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement

Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD

High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)

Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

Cannabis and Opioid Use Disorder

NavSTAR Implementation Effectiveness Trial Across a Health System

Integrating Brain, Neurocognitive, and Computational Tools in OUD

Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Optimization of NIBS for Treatment of Addiction

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

The Youth Opioid Recovery Support (YORS) Intervention

Autobiographical Memory in Opioid Use Disorder

Remotely Observed Methadone Evaluation II

Social Functioning in Opioid Use Disorder

Focused Ultrasound for the Complex Patient

Integrating MOUD in Nonmedical Community Settings (Better Together)

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Frequently Asked Questions